Elewa 2020.

Methods	Design: RCT Setting: Benha University Hospital and Benha Teaching Hospital, Egypt
Participants	Inclusion criteria: age 18 to 40 years, gestational age of 37 to 39 weeks, primigravida or multipara, singleton pregnancy Exclusion criteria: fetuses with major congenital anomalies, medical problems that can affect fetal well‐being, medical or obstetric conditions that warrant early or immediate delivery; women who had received prophylactic dexamethasone during the current pregnancy and those who developed a spontaneous labour
Interventions	Corticosteroid (n = 200): two intramuscular doses of 12 mg dexamethasone 12 hours apart Control (n = 200): IM saline as a placebo in the same regimen as the steroid group
Outcomes	Neonatal respiratory morbidity: respiratory distress, transient tachypnoea and possible persistent pulmonary hypertension of the newborn Agpar scores at 1 and 5 minutes TTN Admission to NICU Mechanical ventilation CPAP Respiratory distress
Notes	Study dates: March 2018 to September 2019 Funding sources: not reported Declarations of interest: not reported We emailed the trial authors on 7 March  2021 to ask for information regarding prospective trial registration, randomisation and number of women lost to follow‐up. Awaiting reply Not included in 2021 update because of lack of response from trial authors regarding our trustworthiness criteria (trial published since 2010 without prospective registration)